<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881515</url>
  </required_header>
  <id_info>
    <org_study_id>819183</org_study_id>
    <nct_id>NCT02881515</nct_id>
  </id_info>
  <brief_title>Adverse Neurogenic Actions of Dietary Salt</brief_title>
  <official_title>Adverse Neurogenic Actions of Dietary Salt</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Delaware</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Delaware</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Excess dietary salt increases the risk for cardiovascular events, even in people that are not&#xD;
      hypertensive. There is some evidence that excess dietary salt exaggerates blood pressure and&#xD;
      sympathetic nervous system responses to various perturbations and increases blood pressure&#xD;
      variability. This proposal will examine the effects of low, medium, and high salt diets on&#xD;
      cardiovascular reactivity and blood pressure variability.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Excess dietary salt causes target organ damage and increases the risk for adverse&#xD;
      cardiovascular (CV) events independent of blood pressure (BP). Recent data in salt-resistant,&#xD;
      normotensive rodents suggest that high dietary salt enhances the excitability or gain of&#xD;
      sympathetic circuits, exaggerates sympathetic and CV responses to various stimuli, and&#xD;
      increases BP variability (BPV). There are limited data regarding the impact of dietary salt&#xD;
      intake on sympathetic nerve activity (SNA) and CV function in salt-resistant humans as well&#xD;
      as the underlying mechanisms contributing to these adverse effects. The long-term goal is to&#xD;
      determine how dietary salt adversely affects BP regulation and CV health. The objective of&#xD;
      this proposal is to comprehensively evaluate the impact of dietary salt intake on SNA and CV&#xD;
      reactivity and BPV in normotensive humans. The investigators have 2 specific aims: 1) Aim 1&#xD;
      will test the hypothesis that high dietary salt increases SNA and CV reactivity in&#xD;
      normotensive adults, 2) Aim 2 will test the hypothesis that high dietary salt increases BPV&#xD;
      in normotensive adults. The expected outcome is to demonstrate that dietary salt loading&#xD;
      increases CV reactivity and BPV through a sympathetic nervous system mechanism that&#xD;
      originates in the brain. The proposed research is significant, as these studies will provide&#xD;
      empirical evidence that dietary salt intake impacts neurohumoral control of the circulation&#xD;
      in salt-resistant humans. The proposed research is innovative because it will identify a&#xD;
      novel neurogenic action of dietary salt in human CV regulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure Variability</measure>
    <time_frame>Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)</time_frame>
    <description>Standard deviation of systolic blood pressure over 24 hours (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure Reactivity - Handgrip exercise</measure>
    <time_frame>Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)</time_frame>
    <description>Change in Blood pressure during handgrip exercise (mmHg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure Reactivity - Cold Pressor test</measure>
    <time_frame>Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)</time_frame>
    <description>Change in Blood pressure during a cold pressor test (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sympathetic Responses - Handgrip exercise</measure>
    <time_frame>Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)</time_frame>
    <description>Sympathetic outflow (bursts per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sympathetic Responses - Cold Pressor test</measure>
    <time_frame>Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)</time_frame>
    <description>Sympathetic outflow (bursts per minute)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Blood Pressure Reactivity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood Pressure Responses to a cold pressor test and acute exercise will be assessed. This will be performed while subjects are on a low sodium diet (1000 mg/daily), medium sodium diet (2300 mg/daily), and high sodium diet (7000 mg/daily).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood Pressure Variability</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twenty four hour blood pressure variability will be assessed. This will be performed while subjects are on a low sodium diet (1000 mg/daily), medium sodium diet (2300 mg/daily), and high sodium diet (7000 mg/daily).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Sodium Diet</intervention_name>
    <description>Ten days of low sodium diet</description>
    <arm_group_label>Blood Pressure Reactivity</arm_group_label>
    <arm_group_label>Blood Pressure Variability</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medium Sodium Diet</intervention_name>
    <description>Ten days of a medium sodium diet</description>
    <arm_group_label>Blood Pressure Reactivity</arm_group_label>
    <arm_group_label>Blood Pressure Variability</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Sodium Diet</intervention_name>
    <description>Ten days of a high sodium diet</description>
    <arm_group_label>Blood Pressure Reactivity</arm_group_label>
    <arm_group_label>Blood Pressure Variability</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  normal blood pressure&#xD;
&#xD;
          -  men, Women, minorities&#xD;
&#xD;
          -  ECG within normal limits&#xD;
&#xD;
          -  screening blood panel within normal limits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  high blood pressure (&gt;140/90 mmHg)&#xD;
&#xD;
          -  history of cardiovascular disease&#xD;
&#xD;
          -  history of cancer&#xD;
&#xD;
          -  history of diabetes&#xD;
&#xD;
          -  history of kidney disease&#xD;
&#xD;
          -  obesity (BMI &gt; 30 kg/m2)&#xD;
&#xD;
          -  smoking or tobacco use&#xD;
&#xD;
          -  current pregnancy&#xD;
&#xD;
          -  nursing mothers&#xD;
&#xD;
          -  communication barriers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William B Farquhar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Delaware</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>William B Farquhar, PhD</last_name>
    <phone>302-831-6178</phone>
    <email>wbf@udel.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Megan Wenner, PhD</last_name>
    <phone>302-831-7343</phone>
    <email>mwenner@udel.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Delaware</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19716</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan M Wenner, MS</last_name>
      <phone>302-831-7343</phone>
      <email>mwenner@udel.edu</email>
    </contact>
    <investigator>
      <last_name>William B Farquhar, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 15, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2016</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Delaware</investigator_affiliation>
    <investigator_full_name>William Farquhar</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

